These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27742352)

  • 1. Black-box warnings could be removed from varenicline.
    Mohammadi D
    Lancet Respir Med; 2016 Nov; 4(11):861. PubMed ID: 27742352
    [No Abstract]   [Full Text] [Related]  

  • 2. New reports examine psychiatric risks of varenicline for smoking cessation.
    Kuehn BM
    JAMA; 2012 Jan; 307(2):129-30. PubMed ID: 22235073
    [No Abstract]   [Full Text] [Related]  

  • 3. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women.
    Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME
    Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
    Yeh JS; Sarpatwari A; Kesselheim AS
    Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline as a Cause of Suicidal Outcomes.
    Hughes JR
    Nicotine Tob Res; 2016 Jan; 18(1):2-9. PubMed ID: 25572451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Food and Drug Administration and varenicline: should risk communication be improved?
    Davies NM; Thomas KH
    Addiction; 2017 Apr; 112(4):555-558. PubMed ID: 27558015
    [No Abstract]   [Full Text] [Related]  

  • 8. Varenicline for smoking cessation.
    Harrison-Woolrych M
    BMJ; 2012 Nov; 345():e7547. PubMed ID: 23138037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypomania following the use of varenicline in two patients with bipolar disorder].
    Sluys ML; Remmers A; Beerthuis RJ
    Tijdschr Psychiatr; 2015; 57(11):835-8. PubMed ID: 26552931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Characteristics of Time-Related Shifts in Suicide-Related Event Frequency During Smoking Cessation Treatment with Varenicline.
    Akimoto H; Wakiyama H; Oshima S; Negishi A; Ohara K; Numajiri S; Okita M; Ohshima S; Inoue N; Kobayashi D
    Int J Med Sci; 2017; 14(10):920-926. PubMed ID: 28924362
    [No Abstract]   [Full Text] [Related]  

  • 11. Varenicline and Suicide: Reconsidered and Reconciled.
    Niaura R
    Nicotine Tob Res; 2016 Jan; 18(1):1. PubMed ID: 26563261
    [No Abstract]   [Full Text] [Related]  

  • 12. Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand.
    Harrison-Woolrych M; Ashton J
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):949-53. PubMed ID: 20602347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of the efficacy and safety of varenicline for smoking cessation after acute coronary syndrome: design and methods of the Evaluation of Varenicline in Smoking Cessation for Patients Post-Acute Coronary Syndrome trial.
    Windle SB; Bata I; Madan M; Abramson BL; Eisenberg MJ
    Am Heart J; 2015 Oct; 170(4):635-640.e1. PubMed ID: 26386786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP
    J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects!
    Prescrire Int; 2014 Sep; 23(152):208. PubMed ID: 25325119
    [No Abstract]   [Full Text] [Related]  

  • 16. Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers.
    Park PW; Casiano EM; Escoto L; Claveria AM
    Curr Med Res Opin; 2011 Oct; 27(10):1869-75. PubMed ID: 21838412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model.
    Knight C; Howard P; Baker CL; Marton JP
    Value Health; 2010; 13(2):209-14. PubMed ID: 19912599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of varenicline for smoking cessation.
    Jung JW; Jeon EJ; Kim JG; Yang SY; Choi JC; Shin JW; Park IW; Choi BW; Kim DK; Kim JY
    Clin Respir J; 2010 Oct; 4(4):215-21. PubMed ID: 20887344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for Patients. Behavioral and Pharmacologic Treatments to Help Adults Quit Smoking: U.S. Preventive Services Task Force Recommendation Statement.
    Ann Intern Med; 2015 Oct; 163(8):I-40. PubMed ID: 26389837
    [No Abstract]   [Full Text] [Related]  

  • 20. Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications.
    Desai RJ; Good MM; San-Juan-Rodriguez A; Henriksen A; Cunningham F; Hernandez I; Good CB
    JAMA Netw Open; 2019 Sep; 2(9):e1910626. PubMed ID: 31483473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.